Compare AKBA & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | SVC |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.0M | 349.6M |
| IPO Year | 2014 | 1995 |
| Metric | AKBA | SVC |
|---|---|---|
| Price | $1.40 | $1.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $5.25 | $2.50 |
| AVG Volume (30 Days) | 2.2M | ★ 18.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ 93.94 | 26.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,814,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $1.13 |
| 52 Week High | $4.08 | $3.08 |
| Indicator | AKBA | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 47.47 |
| Support Level | $1.30 | $1.13 |
| Resistance Level | $1.56 | $2.42 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 33.90 | 81.11 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.